home / stock / abbv / abbv short
Short Information | AbbVie Inc. (NYSE:ABBV)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 640,923 |
Total Actual Volume | 123,246,343 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 32,046 |
Average Short Percentage | 0.67% |
Is there a ABBV Short Squeeze or Breakout about to happen?
See the ABBV Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $173.67 | $172.32 | $173.845 | $171.22 | 4,285,894 | 82,356 | 1.92% |
07-18-2024 | $174.445 | $171.14 | $176.68 | $170.72 | 5,957,924 | 43,537 | 0.73% |
07-17-2024 | $169.51 | $175.27 | $175.74 | $169.51 | 6,983,160 | 18,043 | 0.26% |
07-16-2024 | $168.6 | $169.2 | $169.85 | $167.26 | 3,829,646 | 17,415 | 0.45% |
07-15-2024 | $168.91 | $168.03 | $170.365 | $167.42 | 2,395,181 | 102,896 | 4.3% |
07-12-2024 | $169.0768 | $168.73 | $170.0628 | $168.3535 | 4,133,520 | 20,200 | 0.49% |
07-11-2024 | $167.52 | $169.91 | $170.35 | $167.35 | 3,689,530 | 16,306 | 0.44% |
07-10-2024 | $167.45 | $168.14 | $168.45 | $166.1101 | 3,887,959 | 8,073 | 0.21% |
07-09-2024 | $167.02 | $168.05 | $168.53 | $164.86 | 4,224,705 | 8,079 | 0.19% |
07-08-2024 | $166.54 | $166.52 | $167.717 | $165.62 | 3,500,155 | 11,382 | 0.33% |
07-05-2024 | $164.72 | $167.25 | $167.31 | $163.63 | 5,978,524 | 11,521 | 0.19% |
07-03-2024 | $166.09 | $163.84 | $167.1 | $163.52 | 3,527,612 | 4,841 | 0.14% |
07-02-2024 | $168.63 | $165.96 | $168.63 | $165.45 | 5,965,457 | 24,713 | 0.41% |
07-01-2024 | $171.27 | $170.37 | $173.88 | $169.535 | 5,194,744 | 12,117 | 0.23% |
06-28-2024 | $169.99 | $171.52 | $171.82 | $169.05 | 24,463,599 | 23,461 | 0.1% |
06-27-2024 | $171.29 | $168.99 | $171.555 | $167.75 | 5,381,953 | 78,652 | 1.46% |
06-26-2024 | $170.29 | $171.15 | $172.35 | $170.15 | 5,576,094 | 8,451 | 0.15% |
06-25-2024 | $172.1 | $170.75 | $173.41 | $170.62 | 5,712,698 | 8,883 | 0.16% |
06-24-2024 | $171.13 | $172.74 | $173.41 | $170.7 | 6,249,937 | 8,371 | 0.13% |
06-21-2024 | $172.7 | $170.39 | $172.93 | $169.59 | 12,308,051 | 131,626 | 1.07% |
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 08:25:00 ET Stocks that are trading at low- and discounted-earnings multiples can sometimes be value traps. But other times, it's just due to short-term and temporary factors that the stocks aren't doing terribly well. In these situations, there are opportunities for investors to...
2024-07-14 04:27:00 ET The broader stock market benchmarks keep reaching new heights, but the S&P 500 index's ongoing bull run has been driven heavily by its largest components. That means there are still plenty of reliable dividend-paying stocks that look like bargains. Shares ...
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis PR Newswire Submissions are supported by the Phase 3 SELECT-GCA study demonstrating upadacitinib 15 mg with a 26-week steroid taper regimen achieved the primary endp...